Inventor · disambiguated record
Catherine Castan
Also filed as: CASTAN CATHERINE
15 granted patents·19 pending applications·650 citations·filing 1994–2017
95Inventor score
Files withFLAMEL TECH SA10FLAMEL IRELAND LTD5CASTAN CATHERINE4FLAMEL TECHNOLOGIES S A3GUIMBERTEAU FLORENCE3
Top patents by PatentIndex Score
34 records- 0198USRE47084EOral medicinal product with modified release of at least one active principle in multimicrocapsular formFLAMEL IRELAND LTD·Filed 2016·Granted Oct 16, 2018·36 cites·74 claims
- 0298US9814684B2Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s)FLAMEL IRELAND LTD·Filed 2015·Granted Nov 14, 2017·36 cites·31 claims
- 0398US7906145B2Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s)FLAMEL TECH SA·Filed 2003·Granted Mar 15, 2011·101 cites·25 claims
- 0497US10004693B2Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s)CASTAN CATHERINE·Filed 2011·Granted Jun 26, 2018·36 cites·24 claims
- 0597US7879362B2Oral pharmaceutical compositions with controlled release and prolonged absorptionFLAMEL TECH SA·Filed 2007·Granted Feb 1, 2011·51 cites·21 claims
- 0695US10092511B2Controlled-release floating pharmaceutical compositionsFLAMEL IRELAND LTD·Filed 2016·Granted Oct 9, 2018·43 cites·23 claims
- 0794US8821935B2Microcapsules with modified release of active principles with low solubility for oral deliveryGUIMBERTEAU FLORENCE·Filed 2006·Granted Sep 2, 2014·42 cites·15 claims
- 0894US8101209B2Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principlesLEGRAND VALERIE·Filed 2004·Granted Jan 24, 2012·132 cites·17 claims
- 0993US9561179B2Controlled-release floating pharmaceutical compositionsCASTAN CATHERINE·Filed 2010·Granted Feb 7, 2017·39 cites·14 claims
- 1092US8652523B2Oral pharmaceutical formulation in the form of a plurality of microcapsules for prolonged release of active principle(s) with slow solubilityGUIMBERTEAU FLORENCE·Filed 2003·Granted Feb 18, 2014·42 cites·14 claims
- 1191US8734850B2Oral medicinal product with modified release of at least one active principle in multimicrocapsular formCASTAN CATHERINE·Filed 2004·Granted May 27, 2014·39 cites·28 claims
- 1280US7910133B2Oral pharmaceutical formulation in the form of aqueous suspension of microcapsules for modified release of amoxicillinFLAMEL TECH SA·Filed 2003·Granted Mar 22, 2011·8 cites·24 claims
- 1379US8197850B2Medicine based on anti-hyperglycaemic microcapsules with prolonged release and method for preparing sameCASTAN CATHERINE·Filed 2001·Granted Jun 12, 2012·9 cites·18 claims
- 1466US2017281558A1Oral pharmaceutical formulation in the form of an aqueous suspension of microcapsules for the modified release of active principle(s).FLAMEL IRELAND LTD·Filed 2017·Application pending·0 cites
- 1565US2007173464A1Oral ribavirin pharmaceutical compositionsFLAMEL TECH SA·Filed 2007·Application pending·0 cites
- 1661US2007166378A1Oral ribavirin pharmaceutical compositionsFLAMEL TECHNOLOGIES INC·Filed 2006·Application pending·0 cites
- 1759US2006275376A1Microcapsules with modified release of active principles with low solubility for oral deliveryGUIMBERTEAU FLORENCE·Filed 2003·Application pending·0 cites
- 1855US2009220611A1Microparticles With Modified Release of At Least One Active Principle and Oral Pharmaceutical Form Comprising SameDARGELAS FREDERIC·Filed 2006·Application pending·0 cites
- 1954US2009311315A1Multimicroparticulate Oral Pharmaceutical Form with Modified Release of Angiotensin II Receptor AntagonistsFLAMEL TECHNOLOGIES S A·Filed 2006·Application pending·0 cites
- 2054US2011129539A1Oral pharmaceutical formulation in the form of an aqueous suspension of microcapsules for modified release of amoxicillinFLAMEL TECH SA·Filed 2011·Application pending·0 cites
- 2153US5780579AMethod for the preparation of polyamino acidsFLAMEL TECH SA·Filed 1994·Granted Jul 14, 1998·35 cites·16 claims
- 2253US2004022849A1Oral pharmaceutical composition with controlled release and prolonged absorptionFiled 2001·Application pending·0 cites
- 2353US2010068291A1Oral Medicament Based on a Proton Pump InhibitorFLAMEL TECHNOLOGIES S A·Filed 2006·Application pending·0 cites
- 2452US2004208936A1Novel compositionsFiled 2003·Application pending·0 cites
- 2551US2008026056A1Antibiotic-Based Pharmaceutical Formulation in Microcapsular FormFLAMEL TECH SA·Filed 2005·Application pending·0 cites
- 2650US2010015220A1Niacin and nsaid combination therapyWETTERAU JOHN R·Filed 2009·Application pending·0 cites
- 2744US2015328168A1Oral form, comprising immediate-release coated particles of at least one active compound that are grinding-resistantFLAMEL IRELAND LTD·Filed 2013·Application pending·0 cites
- 2844US2009123536A1Oral Pharmaceutical Form of LosartanFLAMEL TECHNOLOGIES S A·Filed 2006·Application pending·0 cites
- 2943US2008305160A1Oral Medicament For The Modified Release Of At Least One Active Principle, In Multimicrocapsule FormFLAMEL TECH SA·Filed 2005·Application pending·0 cites
- 3042US2004219212A1Single-daily dose antidiabetic oral pharmaceutical form comprising a biguanide and at least another active principleFiled 2002·Application pending·0 cites
- 3142US2005037077A1Galenic microparticulate oral formulation for delayed and controlled release of pharmaceutical active principlesFiled 2002·Application pending·0 cites
- 3241US2006165808A1Microcapsules for the delayed, controlled release of perindoprilHUET DE BAROCHEZ BRUNO·Filed 2003·Application pending·0 cites
- 3337US2011091537A1Anti-misuse solid oral pharmaceutical form provided with a specific modified release profileFLAMEL TECH SA·Filed 2010·Application pending·0 cites
- 3430US5914098AAerosol composition for forming a hydrated membrane, and applications thereofFLAMEL TECH SA·Filed 1994·Granted Jun 22, 1999·1 cites·57 claims
Join the waitlist — get patent alerts
Get an alert when Catherine Castan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →